Learn / LGND
NASDAQ: LGND
Ligand Pharmaceuticals (LGND) stock, explained like you're 5
Ligand Pharmaceuticals trades on the Nasdaq under the ticker LGND. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6 billion dollars.
- Ticker
- LGND
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 6 billion dollars
Is Ligand Pharmaceuticals a small, medium or large cap company?
No. Ligand Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Ligand Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves LGND stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Ligand Pharmaceuticals Incorpor (LGND) Stock Forecasts (Yahoo Finance)
- Here's How Much $1000 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today (Benzinga)
- (LGND) Volatility Zones as Tactical Triggers (Stock Traders Daily)
- Ligand Pharmaceuticals (NASDAQ:LGND) Flashes Strong Trend and High Growth Momentum Despite Setup Caution (ChartMill)
- Barclays sets USD 345.00 target for Ligand Pharmaceuticals stock (ad-hoc-news.de)
Follow LGND in your daily brief
Each trading day at 5 PM ET we post what happened to Ligand Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow LGND
Questions about Ligand Pharmaceuticals stock
What does Ligand Pharmaceuticals do?
Ligand Pharmaceuticals trades on the Nasdaq under the ticker LGND. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6 billion dollars.
What is the ticker symbol for Ligand Pharmaceuticals?
Ligand Pharmaceuticals trades under the ticker LGND on the Nasdaq.
What is Ligand Pharmaceuticals's market cap?
Ligand Pharmaceuticals is a mid cap stock with a market cap of about 6 billion dollars.
How does Ligand Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves LGND stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow LGND stock every day?
Add LGND to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.